Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 598  
 
CASE REPORT
Ahead of Print

COVID-19 messenger ribonucleic acid vaccination and abnormal radiopharmaceutical uptake in the axilla visualized on 68Ga-DOTATATE positron-emission tomography/computed tomography


1 Department of Radiology, Northwestern University Feinberg, School of Medicine, Northwestern University Feinberg, Chicago, IL, USA
2 Department of Radiology, Global Advanced Imaging, PLLC, Little Rock, Arkansas, USA

Correspondence Address:
Twyla Bartel,
Global Advanced Imaging, PLLC, 225 E. Chicago Ave., Box 93, Little Rock 72223, Arkansas
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/wjnm.wjnm_54_21

As COVID-19 vaccination rates continue to rise, it is becoming increasingly important to understand diagnostic imaging associations' resultant from the vaccines. Here, we report a case of a 59-year-old female who was in remission for gastrointestinal neuroendocrine carcinoma and presented for standard follow-up imaging evaluation. Positron-emission tomography (PET) images from a 68Ga-DOTATATE PET (NETSPOT) demonstrated moderate focal radiotracer uptake in the right axilla. Interestingly, this uptake localized to several normal-sized lymph nodes on the corresponding computed tomography (CT). A medical history revealed the patient received both doses of an ipsilateral COVID-19 messenger ribonucleic acid vaccine injection at 17 and 38 days before the PET/CT study. Subsequent scans 2 months later revealed no radiotracer uptake.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Weissman JP
    -  Bartel T
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed115    
    PDF Downloaded6    

Recommend this journal